Regents of the University of California’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Regents of the University of California’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,152	Closed	-$444K	–	38
2021 Q1	$444K	Hold	4,152	–	–	0.06%	29
2020 Q4	$362K	Buy	+4,152	New	+$293K	0.05%	26

Other funds holding NARI

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

DCP

Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Regents of the University of California's NARI Position: Q2 2021 in Review

Regents of the University of California sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2021, closing a stake of 4,152 shares — an estimated $444K sold.

Regents of the University of California first reported a position in NARI in Q4 2020 and held it in 2 quarters. The position peaked at $444K in Q1 2021. 202 funds tracked by Wall St. Rank hold NARI as of Q2 2021.

Regents of the University of California reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Regents of the University of California sold 4,152 Inari Medical, Inc. Common Stock shares in Q2 2021, an estimated $444K.
Regents of the University of California first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
Regents of the University of California's Inari Medical, Inc. Common Stock position peaked at $444K in Q1 2021.
202 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2021.

Based on Regents of the University of California's 13F filing for Q2 2021, filed 27 Jul 2021.